维普期刊资源整合服务平台（V6.5）

77篇 您的检索式：作者名="SCHAPIRA A"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Mitochondrial complex Ⅰ deficiency in Parkinson's disease显示文摘	Schapira A H bCooper J M Dexter D	1990	J Neurochem1990，54，：	1
2	Complex I: inhibitors, inhibition and neurodegeneration 显示文摘	SCHAPIRA A H	2010	Exp Neurol2010，224，2：	1
3	Non-motor symptoms of Parkinsoffs disease:diagnosis and management 显示文摘	Chaudhuri K R Healy D G Schapira A H	2006	Lancet Neurol2006，5，3：	1
4	Mitochondrial disease显示文摘	Schapira A H	2006	Lancet2006，368，：	1
5	Mitochondrial involvement in Parkinson's disease 显示文摘	ORTH M SCHAPIRA A H	2002	Neuro Chem Int2002，40，6：	1
6	Etiology and pathogenesis of Parkinson's disease 显示文摘	Schapira A H Jenner P	2011	Mov Disord2011，26，6：	1
7	Safinamide in the treatment of Parkinson's disease 显示文摘	SCHAPIRA A H	2010	Expert Opin Pharmacother2010，11，13：	1
8	Mitochondrial respiratory chain disorders Ⅱ:neurodegenerative disorders and nuclear gene defects显示文摘	Leonard J V Schapira A H V	2000	The Lancet2000，355，9201：	1
9	Etiopathogenesis and treatment of Parkinson's disease显示文摘	Gallagher D A Schapira A H	2009	Curr Top Med Chem2009，9，10：	1
10	Mitochondrial dysfunction in Parkinson's disease 显示文摘	Schapira A H	2007	Cell Death Differ2007，14，7：	1
11	ct-Synuclein and mitochondrial dysfunction in Parkinson's disease显示文摘	Mullin S Schapira A	2013	Mol Neurobiol2013，47，2：	1
12	Lysosomal dys-function increases exosome-mediated alpha-synuclein release and transmission显示文摘	Alvarez-Erviti L Scow Y Schapira A H	2011	Neurobiol Dis2011，42，3：	1
13	Present and future drug treatment for Parkinson's disease显示文摘	Schapira A H	2005	Journal of Neurology Neurosurgery and Psychiatry2005，76，11：	1
14	Mitochondrial respiratory chain disorders I:mitochondrial DNA defects显示文摘	Leonard J V Schapira A H	2000	Lancet2000，355，：	1
15	Mitochondrial diseases 显示文摘	Schapira A H	2012	The Lancet2012，379，9828：	1
16	The genetics of Parkinson's disease 显示文摘	Mullin S Schapira A	2015	Br Med Bull2015，14，1：	1
17	Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology显示文摘	Grünewald A Gegg ME Taanman JW King RH Kock N Klein C Schapira AH	2009	Exp Neurol2009，219，1：	1
18	Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease显示文摘	SCHAPIRA A H STOCCHI F BORGOHAIN R	2013	European Journal of Neurology2013，20，2：	1
19	Cells beanng mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-induced apoptosis 显示文摘	Danielson SR Wong A Carelli V Martinuzzi A Schapira AH Cortopassi GA	2002	J Biol Chem2002，277，8：	1
20	Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease 显示文摘	Schapira A	2009	Neurology2009，72，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示